POISONS STANDARD AMENDMENT No. 1 OF 2011
 
I, IAN STEHLIK, a delegate of the Secretary to the Department of Health and Ageing for the purposes of paragraph 52D(2)(a) of the Therapeutic Goods Act 1989 (the Act) and acting in accordance with the Secretary’s power under that paragraph of the Act, HEREBY amend the Poisons Standard 2010 in the manner set out in Schedule 1.
 
The amendments to the Poisons Standard 2010 as set out in Schedule 1 commence on
1 June 2011.
 
 
 
(signed by)
 
IAN STEHLIK
Delegate of the Secretary to the Department of Health and Ageing
 
 
Dated this 24th day of May 2011
 
 
 
 
 
 
 
 
 
 
 
 
 
Schedule 1-Amendments to the Poisons Standard 2010
 
 
 
 
 
 
 
STANDARD
FOR THE
UNIFORM SCHEDULING
OF
MEDICINES AND POISONS
 
No. 1
 
 
 
AMENDMENT No. 2
 



Effective Date – 1 June 2011
© Commonwealth of Australia 2011
 
ISBN 978-1-74241-434-8
 
This work is copyright.  Apart from any use as permitted under the Copyright Act 1968, no part may be reproduced by any process without prior written permission from the Commonwealth.  Requests and inquiries concerning reproduction and rights should be addressed to the:
Commonwealth Copyright Administration
Attorney-General’s Department
Robert Garran Offices
National Circuit
BARTON ACT 2600
or at http://www.ag.gov.au/cca
 
Published by the Australian Government under the Therapeutic Goods Act 1989.
 
Publication approval number: D0328
 
 
 
 
 
 
 
The amendments listed in this document are a result of decisions made by the Secretary of the Department of Health and Ageing or the Secretary’s delegate.  The basis of these amendments can be found in the ‘Delegate’s Reasons’, which can be accessed from the scheduling website:
 
http://www.tga.gov.au/industry/scheduling-notices.htm
 
Further inquiries should be directed to:
 
The Secretary
Medicines and Poisons Scheduling Secretariat
Office of Health Protection
Department of Health and Ageing
GPO Box 9848
CANBERRA  ACT  2601
 
Or by email:  SMP@health.gov.au
 
Media Liaison Unit
Australian Government Department of Health and Ageing
TABLE OF CONTENTS



  Part A – AMENDMENTS TO THE SUSMP No. 1                                                                                              i
Part 4 – The Schedules                                                                                                                                      i
Schedule 2 – New Entry                                                                                                                                      1
Schedule 4 – New Entries                                                                                                                                   1
Schedule 4 – Amendments                                                                                                                                  1
 
PART 5 - THE APPENDICES                                                                                                                                  1
 
Appendix H - Amendments                                                                                                                                   1
Part B – Information NOTE                                                                                                                           ii
 
 
Part A – AMENDMENTS TO THE SUSMP No. 1
Amendments to the Standard for the Uniform Scheduling of Medicines and Poisons
 
The Secretary of the Department of Health and Ageing directs that the amendments below be applied to the Standard for the Uniform Scheduling of Medicines and Poisons No. 1 (SUSMP1) and recommends that these amendments be adopted by the States and Territories with effect from 1 June 2011 unless otherwise stated. 
 
Part 4 – The Schedules
SCHEDULE 2 – NEW ENTRY
 
MERCUROCHROME in preparations for external use containing 2 per cent or less of mercurochrome.
SCHEDULE 4 – NEW ENTRIES
 
MERCUROCHROME except when included in Schedule 2 or 6.
OFATUMUMAB.
RILPIVIRINE.
 
TOLVAPTAN.
VINFLUNINE.
SCHEDULE 4 – AMENDMENTS
 
DICLOFENAC – Amend entry to read:
 
DICLOFENAC except:
                        (a) when included in Schedule 2 or 3; or
                        (b) in preparations for dermal use unless:
                                      (i)  for the treatment of solar keratosis; or
                                      (ii) containing more than 1 per cent of diclofenac.
 
Part 5 – The APPENDIces
APPENDIX H – AMENDMENT
PSEUDOEPHEDRINE – Delete entry.
 
Part B – Information NOTE
Amendments set out in subsection 3(2) of the Poisons Standard 2010 will commence 1 June 2011.